New Times,
New Thinking.

  1. Politics
19 October 2009

Labour’s post-conference bounce continues

Conservative lead cut to 11 per cent as Labour rises three points

By Staff Blogger

Labour has narrowed the Conservatives‘ lead to 11 points in a new poll that shows the party’s post-conference bounce continuing. The Sunday Times/YouGov poll put Labour up by three points to 30 per cent, with the Tories unchanged on 41 per cent and the Liberal Democrats unchanged on 17 per cent. Other parties were down three points to 12 per cent.

If repeated at a general election, the findings would give David Cameron’s party a Commons majority of 38.

The Tories continue to lead Labour on economic management although their lead has fallen from 10 to seven points.

Despite Labour’s rise in support much of the electorate remains deeply sceptical of Gordon Brown’s leadership. Voters believe that Labour would do better under an alternative leader by 35 per cent to 10 per cent.

A separate Independent on Sunday/ComRes poll this weekend showed the Conservatives maintaining a 12-point leader over Labour. All the parties were unchanged with the Tories on 40 per cent, Labour on 28 per cent and the Liberal Democrats on 19 per cent.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines

Topics in this article :